Alkermes gets dosing underway in phase 1 ALKS 1140 study

S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Alkermes gets dosing underway in phase 1 ALKS 1140 study

To read the full story on Seeking Alpha, click here.

Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Alkermes Charts.

Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Alkermes Charts.

Alkermes Plc News

Alkermes to Report First Quarter Financial Results on May 1, 2024
Thursday 18 April 2024 (2 days ago) • PR Newswire (US)

Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia
Tuesday 9 April 2024 (2 weeks ago) • PR Newswire (US)

Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society
Monday 8 April 2024 (2 weeks ago) • PR Newswire (US)

Form 8-K - Current report
Thursday 7 March 2024 (1 month ago) • Edgar (US Regulatory)

Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
Thursday 7 March 2024 (1 month ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 24 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 24 February 2024 (2 months ago) • Edgar (US Regulatory)

More Alkermes Plc News Articles

Commonwealth Bank Of Aus...

Australia And New Zealan...

Westpac Banking

Woodside Petroleum

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions